Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Raxibacumab

EU orphan designation number: EU/3/14/1352   
Active ingredient: Raxibacumab
Indication: Treatment of inhalation anthrax disease
Sponsor: GlaxoSmithKline Trading Services Limited
Currabinny, Carrigaline, County Cork, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/10/2014 Orphan designation EMA/OD/134/14 (2014)7651 of 15/10/2014